Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.